OncoSec Medical

OncoSec Medical

OncoSec Medical

We are bio-tech company developing advance stage skin cancer therapies. Our treatment stimulates the body’s own immune system to seek and kill cancerous cells.
Founded
2011
Raised
$46.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$15,000,000
Post-IPO equity - 2018
Alpha Holdings
$163,000
Grant - 2014
National Institute of Health
Team Size
10+
Employees
$15,000,000 Post-IPO equity
FinSMEs

OncoSec Medical Secures $15M Investment from Alpha Holdings

Health Funding